FindMyKOL
Clinical trialNCT05916339RecruitingPhase 4Interventional

AWARE: Management of ADHD in Autism Spectrum Disorder

SponsorDaniel CouryEnrollment500ADHDAutism Spectrum Disorder
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This study is a pragmatic clinical trial examining the comparative effectiveness of two stimulant medications (methylphenidate and amphetamine) in the treatment of ADHD in children and adolescents with autism. Using a sequential, multiple assignment randomization trial (SMART) design the study will not only assess these two medications but also the role of an increasingly popular class of ADHD medication, the alpha-2 agonists. Findings from this study will help improve clinicians' approach to medication selection and reduce the repeated trials of multiple medications that are current standard care.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

13 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Canada
  • University of Alberta, Glenrose Rehabilitation Hospital

    Edmonton, Canada

    Lonnie Zwaigenbaum, MD
    Recruiting
  • Holland Bloorview Kids Rehabilitation Hospital

    Toronto, Canada

    Danielle Baribeau, MD, PhD
    Recruiting
United States
  • University of California, Irvine

    Irvine, California, United States

    Peter Chung, MD
    Recruiting
  • Children'S Hospital Los Angeles

    Los Angeles, California, United States

    Kathryn Smith, RN, MN, DrPH
    Recruiting
  • Maine Medical Center

    Portland, Maine, United States

    Danielle Sipsock, MD
    Recruiting
  • Massachusetts General Hospital Lurie Center for Autism

    Boston, Massachusetts, United States

    Ann Neumeyer, MD
    Recruiting
  • University of Rochester

    Rochester, New York, United States

    Lynn Cole, DNP
    Recruiting
  • Cincinnati Children'S Hospital Medical Center

    Cincinnati, Ohio, United States

    Julia Anixt, MD
    Recruiting
  • Nationwide Children'S Hospital

    Columbus, Ohio, United States

    Eric Butter, PhD
    Recruiting
  • Children'S Hospital of Philadelphia

    Philadelphia, Pennsylvania, United States

    Carlyn Glatts, MD
    Recruiting
  • University of Pittsburgh

    Pittsburgh, Pennsylvania, United States

    Benjamin Handen
    Recruiting
  • Prisma Health Upstate

    Greenville, South Carolina, United States

    Karen L Ratliff-Schaub, MD
    Recruiting
  • University of Virginia

    Charlottesville, Virginia, United States

    Richard Stevenson, MD
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Randomization to either Alpha 2 agonist class of medication or alternate class of stimulantRandomization to either Amphetamine class of stimulant medication or Methylphenidate class of stimulant medication
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
1 Oct 2023
Primary completion
1 Jan 2027
Completion
30 Dec 2027
Last update posted
22 Oct 2026
Registered enrollment
500
Registry id
NCT05916339

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 18 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.